益菌加酸奶品牌怎么样 申请店铺

我要投票 益菌加酸奶在酸奶行业中的票数:274 更新时间:2025-06-04
益菌加酸奶是哪个国家的品牌?「益菌加酸奶」是 江苏益菌加生物科技有限公司 旗下著名品牌。该品牌发源于江苏,由创始人赵丽枫在2010期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力益菌加酸奶品牌出海!将品牌入驻外推网,定制益菌加酸奶品牌推广信息,可以显著提高益菌加酸奶产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

益菌加酸奶怎么样

益菌加酸奶是常州益菌加生物科技有限公司(Probio-Plus)旗下的品牌,公司成立于2010年4月, 是国内唯一中欧合作专业生产乳菌酸及益生菌类活菌制剂冻干粉的内资企业。采用源自保加利亚长寿村的益生菌菌种,使用保加利亚技术,由保加利亚资深乳酸菌发酵专家亲自传授生产工艺并监制生产,采用国际领先的低温三效浓缩技术生产高活力的益生菌冻干粉。

益菌加是2010年常州市领军型创业人才项目,在高效团队的带领下,2011年5月即取得了其它食品(复合乳发酵菌制剂冻干粉)的食品生产许可证,目前为国内唯一一家拥有食品生产许可证的益生菌冻干粉生产企业。ISO22000及食品出口许可备案等体系认证也将在2011年8月之前取得,公司生产车间设计及规格完全按照药品级益生菌生产标准来完成,产品质量,售后服务均有保障。

首期建设规模为年产吨级的多株乳酸菌及益生菌冻干粉(二期建设项目厂址已在选定中)。产品以高活性、高稳定性、高性价比为特点,以适应不同客户的需求,广泛应用于保健品、食品工业和畜牧业。益生菌冻干菌粉生产技术可直接应用于大中型乳制品企业,能为企业开拓第三代功能性乳制品市场。青贮发酵剂,乳酸菌饲料添加剂生产技术可直接应用于各类型饲料加工企业,生产新型微生物饲料,拓展销售市场,经济效益可观。

根据市场调查结果显示,中国每年最少需要十万吨高级营养奶粉,并且国内奶粉市场会以10%以上的速度递增,其中,婴儿粉的增长率将达到15%以上。益生菌做为高级营养奶粉的主要营养添加剂,它的市场需求及增长趋势也是可想而知的。新型饲料添加剂和青贮饲料的生产对乳酸菌的要求更是供不应求,两个行业年增长率可达15%左右。

面对国内市场的巨大潜力,益菌加将凭借科技创新能力大力推动我国益生菌活菌制剂产业的迅速发展;我们立足于中国市场,凭借领军团队与亚洲及欧洲相关产品市场的广泛联系和科研经验,预期成为乳酸菌和益生菌在食品、农用、畜用和环保领域应用、开发、生产的新行业领跑者。


ProBio plus yogurt is a brand of Changzhou ProBio plus Biotechnology Co., Ltd. (ProBio plus). Founded in April 2010, it is the only domestic enterprise that cooperates with China and Europe to produce Lactobacillus acid and probiotic live bacteria preparation freeze-dried powder. Using the probiotic strains from Changshou village, Bulgaria, using Bulgarian technology, the senior Bulgarian lactobacillus fermentation experts personally teach the production process and supervise the production, using the international leading low-temperature three effect concentration technology to produce high activity probiotic freeze-dried powder. Probiotics plus is a leading entrepreneurial talent project of Changzhou City in 2010. Under the leadership of the efficient team, it obtained the food production license of other foods (freeze-dried powder of compound lactobacillus preparation) in May 2011. At present, it is the only probiotics freeze-dried powder production enterprise in China with food production license. ISO22000 and food export license filing system certification will also be obtained before August 2011. The company's production workshop design and specifications are completely completed in accordance with the pharmaceutical probiotic production standards. Product quality and after-sales service are guaranteed. The construction scale of the first phase is tons of lactic acid bacteria and probiotics freeze-dried powder (the site of the second phase construction project has been selected). The products are characterized by high activity, high stability and high cost performance to meet the needs of different customers and are widely used in health products, food industry and animal husbandry. The production technology of probiotic freeze-dried bacterial powder can be directly applied to large and medium-sized dairy enterprises, and can open up the third generation functional dairy market for enterprises. Silage fermentation agent and Lactobacillus feed additive production technology can be directly applied to all kinds of feed processing enterprises to produce new microbial feed and expand the sales market, with considerable economic benefits. According to the market survey results, China needs at least 100000 tons of high-quality nutritional milk powder every year, and the domestic milk powder market will increase by more than 10%, of which the growth rate of infant powder will reach more than 15%. Probiotics as the main nutritional additive of high-grade nutritional milk powder, its market demand and growth trend are also conceivable. The production of new feed additives and silage has a demand for Lactobacillus, and the annual growth rate of the two industries can reach about 15%. In the face of the huge potential of the domestic market, probiotics will vigorously promote the rapid development of China's Probiotic viable pharmaceutical industry by virtue of its scientific and technological innovation ability; based on the Chinese market, with the extensive contact and scientific research experience of the leading Legion team with the relevant product markets in Asia and Europe, we are expected to become the application, development and biology of lactic acid bacteria and probiotics in the fields of food, agriculture, animal use and environmental protection New industry leader in production.

本文链接: https://brand.waitui.com/ab3507fd2.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

奥克股份:与舒泰神合作,提供医药辅料聚乙二醇产品

36氪获悉,奥克股份在互动平台表示,舒泰神(北京)生物制药股份有限公司是公司控股子公司奥克药业的下游客户,主要采购奥克药业的医药辅料聚乙二醇产品。

41分钟前

万泰生物:公司九价HPV疫苗上市许可申请获得批准

36氪获悉,万泰生物公告,公司全资子公司厦门万泰沧海生物技术有限公司申报的九价人乳头瘤病毒疫苗(大肠埃希菌)(商品名称:馨可宁9)获批上市。此前全球范围内仅有一款九价HPV疫苗上市,为默沙东的佳达修®9。该疫苗获批将有利于公司HPV疫苗的推广和使用,丰富公司产品线,进一步增强公司的核心竞争力。但疫苗上市销售时间和市场销售情况存在不确定性。

41分钟前

华域汽车在北京成立汽车座椅新公司

36氪获悉,爱企查App显示,近日,延锋(北京)汽车座椅有限公司成立,法定代表人为李占岭,注册资本5200万元人民币,经营范围包括汽车零部件及配件制造、汽车零配件零售、汽车零配件批发、汽车零部件研发、货物进出口、技术进出口等。股权穿透图显示,该公司由华域汽车旗下延锋国际座椅系统有限公司全资持股。

41分钟前

上海建工:境外全资子公司发行6亿美元债券

36氪获悉,上海建工公告,境外全资子公司永达投资在香港联合交易所完成了美元债发行工作,实际发行总额为6亿美元。

41分钟前

司太立:全资子公司获得碘普罗胺注射液药品注册证书

36氪获悉,司太立公告,全资子公司上海司太立于近日收到国家药监局核准签发的碘普罗胺注射液《药品注册证书》。碘普罗胺注射液适用于诊断用药,用于血管内和体腔内,如计算机X线体层扫描(CT)增强,动脉造影和静脉造影等。该药品的药品注册分类为化学药品4类,且视为通过仿制药质量和疗效一致性评价。碘普罗胺注射液获批上市进一步丰富了公司制剂产品管线。

41分钟前

本页详细列出关于益菌加酸奶的品牌信息,含品牌所属公司介绍,益菌加酸奶所处行业的品牌地位及优势。
咨询